nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—Clemastine—CYP3A4—bone cancer	0.0325	0.209	CrCbGaD
Mesoridazine—Alimemazine—CYP3A4—bone cancer	0.0242	0.155	CrCbGaD
Mesoridazine—Eletriptan—CYP3A4—bone cancer	0.022	0.141	CrCbGaD
Mesoridazine—Mequitazine—CYP3A4—bone cancer	0.0208	0.134	CrCbGaD
Mesoridazine—Pipotiazine—CYP3A4—bone cancer	0.0148	0.0951	CrCbGaD
Mesoridazine—Prochlorperazine—CYP3A4—bone cancer	0.0141	0.0909	CrCbGaD
Mesoridazine—Perphenazine—CYP3A4—bone cancer	0.0101	0.065	CrCbGaD
Mesoridazine—Promazine—CYP3A4—bone cancer	0.00912	0.0586	CrCbGaD
Mesoridazine—Chlorpromazine—CYP3A4—bone cancer	0.00803	0.0516	CrCbGaD
Mesoridazine—KCNH2—Neuronal System—BRAF—bone cancer	0.00224	0.00265	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—SMO—bone cancer	0.00214	0.00254	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—SMO—bone cancer	0.00213	0.00252	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—GRM1—bone cancer	0.00211	0.0025	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—RGS1—bone cancer	0.00206	0.00244	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—GRM4—bone cancer	0.00206	0.00244	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—RGS1—bone cancer	0.00198	0.00235	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—GRM4—bone cancer	0.00198	0.00235	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—GRM4—bone cancer	0.00197	0.00233	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—RGS1—bone cancer	0.00197	0.00233	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—GRM1—bone cancer	0.00197	0.00233	CbGpPWpGaD
Mesoridazine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	0.00196	0.00233	CbGpPWpGaD
Mesoridazine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.00193	0.00228	CbGpPWpGaD
Mesoridazine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.0019	0.00225	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—SMO—bone cancer	0.00188	0.00223	CbGpPWpGaD
Mesoridazine—KCNH2—Neuronal System—MDM2—bone cancer	0.00187	0.00222	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—SMO—bone cancer	0.00185	0.00219	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—SMO—bone cancer	0.00185	0.00219	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—SMO—bone cancer	0.00182	0.00215	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—CDK4—bone cancer	0.00181	0.00214	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—RGS1—bone cancer	0.0018	0.00213	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—GRM4—bone cancer	0.0018	0.00213	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—GRM4—bone cancer	0.00179	0.00212	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—RGS1—bone cancer	0.00179	0.00212	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—GRM1—bone cancer	0.00179	0.00212	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—GRM4—bone cancer	0.00174	0.00206	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—RGS1—bone cancer	0.00174	0.00206	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—GRM1—bone cancer	0.00172	0.00203	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—GRM4—bone cancer	0.00171	0.00203	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—RGS1—bone cancer	0.00171	0.00203	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—GRM1—bone cancer	0.00171	0.00202	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—GRM4—bone cancer	0.00171	0.00202	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—RGS1—bone cancer	0.00171	0.00202	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—GRM4—bone cancer	0.00168	0.00199	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—RGS1—bone cancer	0.00168	0.00199	CbGpPWpGaD
Mesoridazine—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.00165	0.00195	CbGpPWpGaD
Mesoridazine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.00163	0.00193	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	0.00163	0.00193	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—GRM4—bone cancer	0.00158	0.00187	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—RGS1—bone cancer	0.00158	0.00187	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—GRM1—bone cancer	0.00156	0.00185	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—RGS1—bone cancer	0.00155	0.00184	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—GRM4—bone cancer	0.00155	0.00184	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—GRM1—bone cancer	0.00155	0.00184	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—GRM4—bone cancer	0.00155	0.00184	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—RGS1—bone cancer	0.00155	0.00184	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—GRM4—bone cancer	0.00153	0.00181	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—RGS1—bone cancer	0.00153	0.00181	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—JUN—bone cancer	0.00152	0.0018	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—GRM1—bone cancer	0.00151	0.00179	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—GNA11—bone cancer	0.0015	0.00177	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—SMO—bone cancer	0.00148	0.00176	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—GRM1—bone cancer	0.00148	0.00176	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—GRM1—bone cancer	0.00148	0.00175	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—GRM1—bone cancer	0.00146	0.00173	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—GRM4—bone cancer	0.00144	0.0017	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—RGS1—bone cancer	0.00144	0.0017	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	0.0014	0.00166	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	0.00138	0.00163	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—GRM1—bone cancer	0.00137	0.00162	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—GNA11—bone cancer	0.00136	0.00161	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—IL3—bone cancer	0.00136	0.00161	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—GRM1—bone cancer	0.00135	0.0016	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—GRM1—bone cancer	0.00134	0.00159	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—GRM1—bone cancer	0.00132	0.00157	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—GNA11—bone cancer	0.00127	0.0015	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—SMO—bone cancer	0.00126	0.00149	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—GRM1—bone cancer	0.00124	0.00147	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL3—bone cancer	0.00123	0.00146	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—GRM4—bone cancer	0.00122	0.00144	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—RGS1—bone cancer	0.00122	0.00144	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—JUN—bone cancer	0.00117	0.00138	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NDUFA12—bone cancer	0.00116	0.00137	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—GNA11—bone cancer	0.00115	0.00137	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—IL3—bone cancer	0.00115	0.00136	CbGpPWpGaD
Mesoridazine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.00112	0.00133	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—GNA11—bone cancer	0.00111	0.00131	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—GNA11—bone cancer	0.0011	0.0013	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—SMO—bone cancer	0.0011	0.0013	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—SMO—bone cancer	0.00109	0.00129	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—GRM4—bone cancer	0.00106	0.00126	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—RGS1—bone cancer	0.00106	0.00126	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—GRM1—bone cancer	0.00106	0.00125	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—GRM4—bone cancer	0.00106	0.00125	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—RGS1—bone cancer	0.00106	0.00125	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL3—bone cancer	0.00105	0.00124	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—TP53—bone cancer	0.00101	0.00119	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—GNA11—bone cancer	0.00101	0.00119	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—IL3—bone cancer	0.001	0.00119	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—GNA11—bone cancer	0.001	0.00118	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—IL3—bone cancer	0.000998	0.00118	CbGpPWpGaD
Mesoridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000984	0.00117	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—GNA11—bone cancer	0.000972	0.00115	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—SMO—bone cancer	0.000965	0.00114	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—NT5C3A—bone cancer	0.000958	0.00113	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—GNA11—bone cancer	0.000956	0.00113	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—GNA11—bone cancer	0.000954	0.00113	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—SMO—bone cancer	0.000949	0.00112	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—SMO—bone cancer	0.000947	0.00112	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—GNA11—bone cancer	0.000939	0.00111	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GRM4—bone cancer	0.000933	0.00111	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—RGS1—bone cancer	0.000933	0.00111	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—SMO—bone cancer	0.000932	0.0011	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—GRM1—bone cancer	0.000921	0.00109	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GRM4—bone cancer	0.000918	0.00109	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—RGS1—bone cancer	0.000918	0.00109	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—GRM1—bone cancer	0.000917	0.00109	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GRM4—bone cancer	0.000916	0.00108	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—RGS1—bone cancer	0.000916	0.00108	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL3—bone cancer	0.000911	0.00108	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL3—bone cancer	0.000907	0.00107	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GRM4—bone cancer	0.000901	0.00107	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—RGS1—bone cancer	0.000901	0.00107	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—GNA11—bone cancer	0.000882	0.00105	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—IL3—bone cancer	0.000881	0.00104	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SMO—bone cancer	0.000877	0.00104	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—GNA11—bone cancer	0.000868	0.00103	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—IL3—bone cancer	0.000867	0.00103	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—GNA11—bone cancer	0.000866	0.00103	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—IL3—bone cancer	0.000865	0.00102	CbGpPWpGaD
Mesoridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000854	0.00101	CbGpPWpGaD
Mesoridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000853	0.00101	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—GNA11—bone cancer	0.000853	0.00101	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—IL3—bone cancer	0.000851	0.00101	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GRM1—bone cancer	0.000809	0.000958	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—GNA11—bone cancer	0.000802	0.00095	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL3—bone cancer	0.0008	0.000948	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GRM1—bone cancer	0.000796	0.000943	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GRM1—bone cancer	0.000794	0.000941	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL3—bone cancer	0.000787	0.000932	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL3—bone cancer	0.000786	0.00093	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GRM1—bone cancer	0.000782	0.000926	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL3—bone cancer	0.000773	0.000915	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—TP53—bone cancer	0.000769	0.000911	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—ATF1—bone cancer	0.000746	0.000883	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SMO—bone cancer	0.000745	0.000882	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL3—bone cancer	0.000727	0.000861	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—GNA11—bone cancer	0.000681	0.000807	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SMO—bone cancer	0.000649	0.000769	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SMO—bone cancer	0.000646	0.000765	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—ATF1—bone cancer	0.000633	0.00075	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TGFBR2—bone cancer	0.000622	0.000737	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL3—bone cancer	0.000618	0.000731	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—GNA11—bone cancer	0.000594	0.000703	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—GNA11—bone cancer	0.000591	0.0007	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IGF1R—bone cancer	0.000585	0.000693	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SMO—bone cancer	0.00057	0.000675	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SMO—bone cancer	0.000561	0.000664	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SMO—bone cancer	0.00056	0.000663	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—ATF1—bone cancer	0.000552	0.000654	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SMO—bone cancer	0.000551	0.000652	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—ATF1—bone cancer	0.000549	0.00065	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL3—bone cancer	0.000538	0.000638	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL3—bone cancer	0.000536	0.000634	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TGFBR2—bone cancer	0.000528	0.000626	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GNA11—bone cancer	0.000521	0.000617	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GNA11—bone cancer	0.000513	0.000607	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GNA11—bone cancer	0.000512	0.000606	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GNA11—bone cancer	0.000504	0.000596	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IGF1R—bone cancer	0.000497	0.000589	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ATF1—bone cancer	0.000485	0.000574	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ATF1—bone cancer	0.000477	0.000565	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ATF1—bone cancer	0.000476	0.000564	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL3—bone cancer	0.000473	0.00056	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ATF1—bone cancer	0.000468	0.000555	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL3—bone cancer	0.000465	0.000551	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL3—bone cancer	0.000464	0.00055	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	0.00046	0.000545	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	0.000458	0.000542	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL3—bone cancer	0.000457	0.000541	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IGF1R—bone cancer	0.000433	0.000513	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IGF1R—bone cancer	0.000431	0.00051	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—KIT—bone cancer	0.000424	0.000503	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ENO2—bone cancer	0.000419	0.000497	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TGFBR2—bone cancer	0.000404	0.000479	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—BRAF—bone cancer	0.000399	0.000472	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	0.000398	0.000471	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TGFBR2—bone cancer	0.000397	0.00047	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	0.000391	0.000462	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—DHFR—bone cancer	0.000389	0.000461	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—EGFR—bone cancer	0.000387	0.000458	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IGF1R—bone cancer	0.00038	0.00045	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IGF1R—bone cancer	0.000374	0.000443	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IGF1R—bone cancer	0.000373	0.000442	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IGF1R—bone cancer	0.000367	0.000435	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GNA11—bone cancer	0.000364	0.000431	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—KIT—bone cancer	0.00036	0.000427	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—BRAF—bone cancer	0.000339	0.000401	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MDM2—bone cancer	0.000334	0.000396	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP3A4—bone cancer	0.00033	0.00039	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—EGFR—bone cancer	0.000328	0.000389	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—KIT—bone cancer	0.000314	0.000372	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—KIT—bone cancer	0.000313	0.00037	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—BRAF—bone cancer	0.000295	0.00035	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—BRAF—bone cancer	0.000294	0.000348	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—JUN—bone cancer	0.000291	0.000344	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—EGFR—bone cancer	0.000286	0.000339	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—EGFR—bone cancer	0.000285	0.000337	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MDM2—bone cancer	0.000284	0.000336	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MMP9—bone cancer	0.000283	0.000335	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—GSTP1—bone cancer	0.000282	0.000334	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—KIT—bone cancer	0.000276	0.000327	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—KIT—bone cancer	0.000271	0.000321	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—KIT—bone cancer	0.000271	0.000321	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—KIT—bone cancer	0.000266	0.000316	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—BRAF—bone cancer	0.000259	0.000307	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—BRAF—bone cancer	0.000255	0.000302	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—BRAF—bone cancer	0.000255	0.000301	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—EGFR—bone cancer	0.000251	0.000298	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—BRAF—bone cancer	0.00025	0.000297	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MDM2—bone cancer	0.000247	0.000293	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—EGFR—bone cancer	0.000247	0.000293	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—JUN—bone cancer	0.000247	0.000292	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—EGFR—bone cancer	0.000247	0.000292	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MDM2—bone cancer	0.000246	0.000292	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—EGFR—bone cancer	0.000243	0.000288	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MMP9—bone cancer	0.00024	0.000284	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EGFR—bone cancer	0.000228	0.000271	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MDM2—bone cancer	0.000217	0.000257	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—JUN—bone cancer	0.000215	0.000255	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—JUN—bone cancer	0.000214	0.000253	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MDM2—bone cancer	0.000214	0.000253	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MDM2—bone cancer	0.000213	0.000253	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MDM2—bone cancer	0.00021	0.000249	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MMP9—bone cancer	0.000209	0.000248	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MMP9—bone cancer	0.000208	0.000247	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EGFR—bone cancer	0.000194	0.00023	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TP53—bone cancer	0.000192	0.000227	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—JUN—bone cancer	0.000189	0.000224	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—JUN—bone cancer	0.000186	0.00022	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—JUN—bone cancer	0.000185	0.00022	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MMP9—bone cancer	0.000184	0.000218	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—JUN—bone cancer	0.000182	0.000216	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MMP9—bone cancer	0.000181	0.000214	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MMP9—bone cancer	0.00018	0.000214	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MMP9—bone cancer	0.000177	0.00021	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EGFR—bone cancer	0.000169	0.0002	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EGFR—bone cancer	0.000168	0.000199	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TP53—bone cancer	0.000163	0.000193	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGFR—bone cancer	0.000148	0.000176	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTGS2—bone cancer	0.000146	0.000173	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGFR—bone cancer	0.000146	0.000173	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGFR—bone cancer	0.000146	0.000173	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGFR—bone cancer	0.000143	0.00017	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TP53—bone cancer	0.000142	0.000168	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TP53—bone cancer	0.000141	0.000167	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TP53—bone cancer	0.000125	0.000148	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TP53—bone cancer	0.000123	0.000145	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TP53—bone cancer	0.000122	0.000145	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TP53—bone cancer	0.00012	0.000143	CbGpPWpGaD
